Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06995937 · ClinicalTrials.gov registry record

Medical Marijuana and Open Road Driving Task

A clinical trial of Medical Cannabis, sponsored by Florida State University.

Recruiting
Registry status
250
Enrollment target
2
Study locations

NCT06995937: Recruiting study of Medical Cannabis, sponsored by Florida State University.

NCT06995937 is a study of Medical Cannabis that is actively recruiting participants, run by Florida State University. The registered enrollment target is 250 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06995937, a study of Medical Cannabis, is actively recruiting participants, sponsored by Florida State University.

RECRUITING
Registry status
250 participants
Enrollment target
2
Study locations

Study Summary

Medical marijuana use among adults 50 and older has more than doubled in the past decade with exponential increases projected in this demographic by 2050, and prescription opioids are one of the most common treatments for pain management in this population. To date, no studies systematically assess driving performance in a rigorous and ecologically valid manner accounting for long-term medical marijuana use and/or the combined effect of prescription opioid use in adults 50 and older who endorse chronic or severe non-malignant pain. Further, studies examining how older adults self-regulate prescription medication use and driving behavior is limited, with none rigorously examining medical marijuana.

Primary Outcome

A standardized score sheet with a total of 49 driving maneuvers and eight types of possible driving errors is used by the Certified Driver Rehabilitation Specialist while the participant is driving. The driving errors are lane maintenance errors, speed regulation errors, adjustment-to-stimuli errors, yielding errors, signaling errors, vehicle positioning errors, visual scanning, and gap acceptance errors. For each maneuver, a maximum score of 3 is given if no errors are committed. At the end of

Conditions Studied

Study Locations (2)

Florida

  • University of Florida - Gainesville
  • Florida State University, Center for Translational Behavioral Science - Tallahassee

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2025-05-19
Est. Completion 2029-01-30
Florida State University

219 total trials

What NCT06995937 shows while recruiting

NCT06995937 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Medical Cannabis appearing as the primary indexed condition, and to 0 interventions.

NCT06995937 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06995937 about?

NCT06995937 is a clinical study titled "Medical Marijuana and Open Road Driving Task". Medical marijuana use among adults 50 and older has more than doubled in the past decade with exponential increases projected in this demographic by 2050, and prescription opioids are one of the most common treatments for pain management in this population. To date, no studies systematically assess ...

What is the current status of trial NCT06995937?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2025-05-19. Estimated completion is 2029-01-30.

What conditions does trial NCT06995937 study?

This clinical trial studies the following conditions: Medical Cannabis.

Who is sponsoring clinical trial NCT06995937?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06995937 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06995937, the US trial registry maintained by the National Library of Medicine. NCT06995937 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.